InsiderClue
← All stocks

Revolution Medicines, Inc.

RVMD Scheduled selling only
CIK 0001628171 #590 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$66.74M
$14.97M on a plan · $51.77M straight out of an exercise
Sold at will
$0.00
0 of 51 sales
Net
−$66.74M
$0.00 against sales at will

By person

17 insiders · 51 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kelsey Stephen Michael
See Remarks
—
$18.72M (8) scheduled
−$18.72M
291,876
0.1362%
$60.07M
+9.8%
GOLDSMITH MARK A
See Remarks
—
$17.99M (18) scheduled
−$17.99M
328,754
0.1534%
$67.66M
+102.4%
Kim Lorence H.
Director
—
$14.97M (14) scheduled
−$14.97M
1,191
0.0006%
$245.12K
−98.3%
Cislini Jeff
General Counsel
—
$11.90M (6) scheduled
−$11.90M
55,907
0.0261%
$11.51M
+20.9%
Mancini Anthony
See Remarks
—
$3.15M (5) scheduled
−$3.15M
43,890
0.0205%
$9.03M
−19.6%
Borisy Alexis
Director
—
—
—
2,340,075
1.09%
$481.60M
+0.2%
Schroeder Thilo
Director
—
—
—
760,869
0.3550%
$156.59M
—
Horn Margaret A
Chief Operating Officer
—
—
—
154,647
0.0722%
$31.83M
+15.7%
Anders Jack
Chief Financial Officer
—
—
—
123,269
0.0575%
$25.37M
+23.0%
Wang Xiaolin
See Remarks
—
—
—
116,063
0.0541%
$23.89M
+33.9%
Wei Lin
Chief Medical Officer
—
—
—
101,366
0.0473%
$20.86M
−10.7%
Horning Sandra
Director
—
—
—
97,765
0.0456%
$20.12M
+4.6%
Borellini Flavia
Director
—
—
—
26,215
0.0122%
$5.40M
+19.8%
ANDERSON ELIZABETH M
Director
—
—
—
24,406
0.0114%
$5.02M
+21.6%
Patel Sushil
Director
—
—
—
21,656
0.0101%
$4.46M
+8.6%
Weber Barbara
Director
—
—
—
13,065
0.0061%
$2.69M
−28.5%
Clyburn Frank
Director
—
—
—
10,929
0.0051%
$2.25M
+57.7%

Individual transactions

51
Insider
Date
Role
Action
Shares
Price
Amount
Kelsey Stephen Michael
11 Sep 2026
See Remarks
Sold after exercise
3,270
$205.81
$672.99K
Kelsey Stephen Michael
11 Sep 2026
See Remarks
Sold after exercise
4,995
$204.84
$1.02M
Kelsey Stephen Michael
11 Sep 2026
See Remarks
Sold after exercise
17,949
$203.87
$3.66M
Kelsey Stephen Michael
11 Sep 2026
See Remarks
Sold after exercise
18,869
$203.06
$3.83M
Kelsey Stephen Michael
11 Sep 2026
See Remarks
Sold after exercise
21,447
$201.75
$4.33M
Kelsey Stephen Michael
11 Sep 2026
See Remarks
Sold after exercise
13,368
$200.78
$2.68M
Kelsey Stephen Michael
11 Sep 2026
See Remarks
Sold after exercise
11,833
$200.11
$2.37M
Kelsey Stephen Michael
11 Sep 2026
See Remarks
Sold after exercise
800
$198.55
$158.84K
Mancini Anthony
10 Sep 2026
See Remarks
Sold after exercise
300
$207.17
$62.15K
Mancini Anthony
10 Sep 2026
See Remarks
Sold after exercise
1,179
$206.10
$242.99K
Mancini Anthony
10 Sep 2026
See Remarks
Sold after exercise
2,420
$205.05
$496.22K
Mancini Anthony
10 Sep 2026
See Remarks
Sold after exercise
5,530
$204.14
$1.13M
Mancini Anthony
10 Sep 2026
See Remarks
Sold after exercise
6,019
$203.28
$1.22M
Kim Lorence H.
8 Sep 2026
Director
Sold on a plan indirect
371
$212.27
$78.75K
Kim Lorence H.
8 Sep 2026
Director
Sold on a plan indirect
3,844
$211.36
$812.46K
Kim Lorence H.
8 Sep 2026
Director
Sold on a plan indirect
4,730
$210.50
$995.68K
Kim Lorence H.
8 Sep 2026
Director
Sold on a plan indirect
2,853
$209.56
$597.87K
Kim Lorence H.
8 Sep 2026
Director
Sold on a plan indirect
3,587
$208.55
$748.08K
Kim Lorence H.
8 Sep 2026
Director
Sold on a plan indirect
999
$207.33
$207.12K
Kim Lorence H.
8 Sep 2026
Director
Sold on a plan indirect
706
$206.60
$145.86K
Kim Lorence H.
31 Aug 2026
Director
Sold on a plan indirect
625
$206.15
$128.85K
Kim Lorence H.
31 Aug 2026
Director
Sold on a plan indirect
2,128
$205.19
$436.64K
Kim Lorence H.
31 Aug 2026
Director
Sold on a plan indirect
7,271
$204.35
$1.49M
Kim Lorence H.
31 Aug 2026
Director
Sold on a plan indirect
26,160
$203.55
$5.32M
Kim Lorence H.
31 Aug 2026
Director
Sold on a plan indirect
12,919
$202.48
$2.62M
Kim Lorence H.
31 Aug 2026
Director
Sold on a plan indirect
6,597
$201.47
$1.33M
Kim Lorence H.
31 Aug 2026
Director
Sold on a plan indirect
300
$200.56
$60.17K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
126
$212.06
$26.72K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
229
$211.46
$48.43K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
126
$210.40
$26.51K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
1,405
$209.27
$294.02K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
937
$208.36
$195.23K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
177
$207.25
$36.68K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
127
$212.06
$26.93K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
245
$211.47
$51.81K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
136
$210.40
$28.61K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
1,351
$209.28
$282.74K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
951
$208.36
$198.15K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise indirect
190
$207.25
$39.38K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise
3,621
$212.08
$767.93K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise
6,583
$211.33
$1.39M
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise
3,813
$210.25
$801.67K
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise
35,938
$209.26
$7.52M
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise
24,917
$208.37
$5.19M
GOLDSMITH MARK A
21 Aug 2026
See Remarks
Sold after exercise
5,128
$207.23
$1.06M
Cislini Jeff
21 Aug 2026
General Counsel
Sold after exercise
3,314
$212.06
$702.76K
Cislini Jeff
21 Aug 2026
General Counsel
Sold after exercise
4,500
$211.34
$951.04K
Cislini Jeff
21 Aug 2026
General Counsel
Sold after exercise
2,540
$210.26
$534.07K
Cislini Jeff
21 Aug 2026
General Counsel
Sold after exercise
25,817
$209.25
$5.40M
Cislini Jeff
21 Aug 2026
General Counsel
Sold after exercise
17,323
$208.37
$3.61M
Cislini Jeff
21 Aug 2026
General Counsel
Sold after exercise
3,400
$207.24
$704.60K

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 37
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 238,174
History held since 14 Feb 2020